2345

Synthetic Diffusion-Weighted MRI in Patients with Hepatocellular Carcinoma: Feasibility and Performance Versus the Conventional Acquired  
Shan Yao1, Yi Wei1, Zheng Ye1, and Bin Song1
1Department of Radiology, West China Hospital, Sichuan University, Chengdu, China

Synopsis

Hepatocellular carcinoma (HCC) is the most common malignancy cancer and the second major contributor to cancer-related mortality worldwide. Diffusion-weighted imaging (DWI) has been widely used in HCC evaluation and showed great potential, while with some limitations like low SNRs and artifacts causing by high b values, and prolonged acquisition time. Synthetic DWI is mathematically derived from directly acquired DWI with at least two different b-values, which may tackle the limitations of conventional acquired DWI. This study aims to investigate the clinical feasibility and diagnosis performance of synthetic DWI in patients with HCC compared with conventional acquired DWI qualitatively and quantitatively.

INTRODUCTION
Hepatocellular carcinoma (HCC) is the most common malignancy cancer with fast rising incidence in both men and women and the second major contributor to cancer-related mortality worldwide1, 2. Diffusion-weighted imaging (DWI), an unenhanced, robust and reliable technique which has been widely used in the evaluation of liver tumors and showed its usefulness and potential in HCC diagnosis3-6. However, acquired high b-value results in low signal-to-noise ratios (SNRs) and artifacts such as eddy current-induced distortions, with prolonged acquisition time as requirement of longer echo times (TEs)7. By contrast, synthetic DWI is a mathematical computation technique using derived apparent diffusion coefficient (ADC) and acquired b-values to synthesize desired b-values images with at least two different b-values7, which may tackle the limitations of conventional directly acquired DWI by achieving background suppression of a very high b-value DWI without additional acquisition scan time. Though previous studies have demonstrated the usefulness of synthetic DWI in detection of prostate cancers, pancreatic cancers, hepatic metastases, and breast cancers8-15, almost no study has focused on synthetic DWI in HCC evaluation. Therefore, the purpose of this study is to investigate the clinical feasibility and diagnosis performance of synthetic DWI in patients with HCC compared with conventional acquired DWI qualitatively and quantitatively.
METHODS
This prospective study was approved by the Institutional Review Board with written informed consent obtained. Twenty-seven patients with HCC were prospectively involved undergoing conventional acquired DWI at b-values of 50, 800, 1000, 1200, and 1400 s/mm2 and synthetic DWI, of which synthetic images were calculated at b=1000, 1200, and 1400 s/mm2 from acquired images using b-values of 200 and 600 s/mm2. Two readers reviewed image sets of both synthetic and conventional acquired images of 1000, 1200, and 1400 s/mm2 independently and rated image quality and lesion conspicuity. Overall image quality was assessed using 4-point scale: 1=poor, 2=moderate, 3=good, 4=excellent, and lesion conspicuity based on 5-point scale: 1=barely conspicuous, 2=fairly conspicuous, 3=moderately conspicuous, 4=well seen, 5=very well and sharply defined. Signal intensity (SI) was measured by placing round regions of interest (ROIs) on lesions and liver parenchyma avoiding any focal lesions and major vessels. Quantitative analysis was performed as follows: signal-to-noise ratio (SNR) = SIlesion / SDbackground noise, contrast-to-noise ratio (CNR) = (SIlesion - SIliver parenchyma) / SDbackground noise, SIR= SIlesion / SIliver parenchyma, cancer-to-parenchyma contrast ratio =(SIliver parenchyma - SIlesion) / (SIliver parenchyma + SIlesion). The grading scores at different b values were compared using the Friedman test. SNR, CNR, and SIR were compared using analysis of variance. In case of significant results, post-hoc analysis was performed. The interobserver agreement were also evaluated by intraclass correlation coefficient (ICC) for quantitative assessment. Two-sided p value <0.05 was considered as statistically significant.
RESULTS
There were no significant differences in overall image quality at synthetic DWI1000, conventional DWI1000, synthetic DWI1200, and conventional DWI1200 (p>0.05), whereas synthetic DWI1400 showed lower overall image quality than other DWI sets (p<0.001). Comparison of lesion conspicuity at both synthetic and conventional acquired three DWI sets revealed no significant differences (p>0.05). SNR, CNR and SIR showed a continuous decrease with increasing b-values, with significant differences between each of b-values sets (P<0.001), while comparison between synthetic DWI1000 and conventional DWI1000, synthetic DWI1200 and conventional DWI1200, synthetic DWI1400 and conventional DWI1400 presented no significant difference (p>0.05). Cancer-to-parenchyma contrast ratio almost unchanging showed no significant difference (p>0.05). Both readers showed similar assessment in SNR, CNR, SIR and cancer-to-parenchyma contrast ratio at all DWI sets, with moderate to good interobserver agreement (ICC=0.63-0.81, P<0.05).
CONCLUSION
Synthetic DWI is of great comparable image quality and lesion conspicuity in HCC diagnosis versus conventional acquired DWI, while reducing scan time and avoiding the disadvantages of performing DWI at high b-values.

Acknowledgements

No acknowledgement found.

References

REFERENCES

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69(1):7-34.

2. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. Ca Cancer J Clin 2016;66(2):115-32.

3. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging 2009;29(2):341-9.

4. Saito K, Araki Y, Park J, et al. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. J Magn Reson Imaging 2010;32(1):229-34.

5. Nishie A, Tajima T, Ishigami K, et al. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI). J Magn Reson Imaging 2010;31(2):373-82.

6. Rimola J, Forner A, Sapena V, et al. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma. Eur Radiol 2020;30(1):186-94.

7. Blackledge MD, Leach MO, Collins DJ, Koh DM. Computed diffusion-weighted MR imaging may improve tumor detection. Radiology 2011;261(2):573-81.

8. Rosenkrantz AB, Chandarana H, Hindman N, et al. Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection. Eur Radiol 2013;23(11):3170-7.

9. Jendoubi S, Wagner M, Montagne S, et al. MRI for prostate cancer: can computed high b-value DWI replace native acquisitions? Eur Radiol 2019;29(10):5197-204.

10. Fukukura Y, Kumagae Y, Hakamada H, et al. Computed diffusion-weighted MR imaging for visualization of pancreatic adenocarcinoma: Comparison with acquired diffusion-weighted imaging. Eur J Radiol 2017;95:39-45.

11. Shimizu H, Isoda H, Fujimoto K, et al. Comparison of acquired diffusion weighted imaging and computed diffusion weighted imaging for detection of hepatic metastases. Eur J Radiol 2013;82(3):453-8.

12. Kawahara S, Isoda H, Fujimoto K, et al. Additional benefit of computed diffusion-weighted imaging for detection of hepatic metastases at 1.5T. Clin Imaging 2016;40(3):481-5.

13. Bickel H, Polanec SH, Wengert G, et al. Diffusion-Weighted MRI of Breast Cancer: Improved Lesion Visibility and Image Quality Using Synthetic b-Values. J Magn Reson Imaging 2019;50(6):1754-61.

14. Daimiel Naranjo I, Lo Gullo R, Saccarelli C, et al. Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI. Eur Radiol 2020.

15. Choi BH, Baek HJ, Ha JY, et al. Feasibility Study of Synthetic Diffusion-Weighted MRI in Patients with Breast Cancer in Comparison with Conventional Diffusion-Weighted MRI. Korean J Radiol 2020;21(9):1036-44.

Proc. Intl. Soc. Mag. Reson. Med. 29 (2021)
2345